The role of dual antithrombotic strategy (low-dose rivaroxaban + aspirin) in therapy: Joint consensus document of the Hungarian Society of Angiology and Vascular Surgery (MAÉT), the Hungarian Society of Cardiology (MKT) and the Hungarian Stroke Society (MST)

Every second person in Hungary dies because of cardiovascular disease. Cardiovascular (CV) disease and mortality are more common in patients who have already had a CV event. Thus, secondary prevention treatment is of paramount importance in improving morbidity and mortality indicators in Hungary. On...

Descripció completa

Dades bibliogràfiques

Autors principals:	Zoltán Járai, Dániel Aradi, László Szapáry, Katalin Farkas, Késmárky Gábor, Kolossváry Endre, Zsolt Palásthy, Dávid Becker, Róbert Gábor Kiss, András Komócsi
Format:	Artigo
Idioma:	Inglês
Publicat:	Promenade Kft 2025-02-01
Col·lecció:	Cardiologia Hungarica
Matèries:	atherosclerotic vascular diseases prevention antithrombotic therapy rivaroxaban aspirin
Accés en línia:	https://cardiologia.hungarica.eu/archive/2025-issues/volume-55-issue-1/the-role-of-dual-antithrombotic-strategy-low-dose-rivaroxaban-aspirin-in-therapy-joint-consensus-document-of-the-hungarian-society-of-angiology-and-vascular-surgery-mat-the-hungarian-society-of-cardiology-mkt-and-the-hungarian-stroke-society-mst
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!